Off-label use of antiretroviral drugs: ethical and legal implications for clinical decision-making

AIDS Reviews · Published 2026-07-03 · DOI 10.24875/aidsrev.26000007

Free full text

Authors (4)

Alba Rodríguez-García, Andrea Drozdz-Vergara, Esther Domingo-Chiva, Gemma Blázquez-Abellán

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Rodríguez-García, A., Drozdz-Vergara, A., Domingo-Chiva, E., et al. (2026). Off-label use of antiretroviral drugs: ethical and legal implications for clinical decision-making. AIDS Reviews. https://doi.org/10.24875/aidsrev.26000007

Related articles

• Why is the Bill and Melinda Gates Foundation going extinct? · AIDS Reviews · 2025 · Same journal
• Immunopathology and therapeutic strategies for long COVID: mechanisms, manifestations, and clinical implications · AIDS Reviews · 2025 · Same journal
• New CDC guidelines for HIV post-exposure prophylaxis · AIDS Reviews · 2025 · Same journal
• HTLV in Sweden · AIDS Reviews · 2024 · Same journal
• Risk factors and mortality outcomes of COVID-19 in people living with HIV: a systematic review and meta-analysis · AIDS Reviews · 2024 · Same journal
• HIV/HBV coinfection: understanding the complex interactions and their impact on spontaneous HBV clearance, chronic liver damage, cirrhosis, and hepatocellular carcinoma · AIDS Reviews · 2024 · Same journal
• The impact of the M184V resistance mutation on treatment outcomes in patients with HIV infection: a systematic review and meta-analysis · AIDS Reviews · 2023 · Same journal
• Prevalence and risk factors for HIV infection in truck drivers: a systematic review of global evidence · AIDS Reviews · 2024 · Same journal
• Current challenges in caring for injection drug users with human immunodeficiency virus infection in Pakistan · AIDS Reviews · 2026 · Same journal
• Can Google DeepMind unlock the mystery of lifeÓ?s origin? · AIDS Reviews · 2026 · Same journal